The marine sponge metabolite mycothiazole: A novel prototype mitochondrial complex I inhibitor
Open Access
- 1 August 2010
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 18 (16) , 5988-5994
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A Selective Account of Effective Paradigms and Significant Outcomes in the Discovery of Inspirational Marine Natural ProductsJournal of Natural Products, 2009
- Methylalpinumisoflavone Inhibits Hypoxia-inducible Factor-1 (HIF-1) Activation by Simultaneously Targeting Multiple PathwaysJournal of Biological Chemistry, 2009
- Marine natural products as inhibitors of hypoxic signaling in tumorsPhytochemistry Reviews, 2009
- Paw Paw and Cancer: Annonaceous Acetogenins from Discovery to Commercial ProductsJournal of Natural Products, 2008
- Mitochondrial complex III regulates hypoxic activation of HIFCell Death & Differentiation, 2008
- Sponge-Derived Fijianolide Polyketide Class: Further Evaluation of Their Structural and Cytotoxicity PropertiesJournal of Medicinal Chemistry, 2007
- Targeting VEGF-A to Treat Cancer and Age-Related Macular DegenerationAnnual Review of Medicine, 2007
- Synthesis and biological evaluation of simplified mycothiazole analoguesBioorganic & Medicinal Chemistry Letters, 2006
- A Reassignment of (−)-Mycothiazole and the Isolation of a Related DiolJournal of Natural Products, 2006
- Molecular-Targeted Antitumor Agents: The Saururus cernuus Dineolignans Manassantin B and 4-O-Demethylmanassantin B Are Potent Inhibitors of Hypoxia-Activated HIF-1Journal of Natural Products, 2004